Tahira Khan

Clinical Operations Consultant (Europe). Previously Theragnostics, AstraZeneca

Tahira joined CellCentric in 2020, bringing with her over 22 years of clinical delivery and strategy experience. She graduated with a BSc in Pharmacology and has an MSc in Clinical Research.

Tahira has worked in all phases of clinical development from Phase I to post marketing surveillance, with a strong emphasis in Oncology. Her experience has involved significant time within academia (St James' University Hospital, LGI), CROs, Pharma and Biotechs. 

Tahira was previously Associate Director of Study Management at Astra Zeneca for a number of first-time-in-man and early phase studies.  More recently Tahira was the Clinical Director at Theragnostics, a biotech company providing a portfolio of oncology products including molecular radiotherapy and molecular imaging diagnostic products. Tahira was responsible for clinical planning and delivery.